Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Clinical Oncology/Epidemiology
  • Published:

Clinical Oncology/Epidemiology

Enhancement of the antiemetic action of ondansetron by transcutaneous electrical stimulation of the P6 antiemetic point, in patients having highly emetic cytotoxic drugs

British Journal of Cancer volume 64, pages 971–972 (1991)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Northern Ireland Centre for Radiotherapy and Oncology, Belvoir Park Hospital, Belfast

    C McMillan

Authors
  1. C McMillan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. JW Dundee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. WP Abram
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McMillan, C., Dundee, J. & Abram, W. Enhancement of the antiemetic action of ondansetron by transcutaneous electrical stimulation of the P6 antiemetic point, in patients having highly emetic cytotoxic drugs. Br J Cancer 64, 971–972 (1991). https://doi.org/10.1038/bjc.1991.439

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1991.439

Search

Advanced search

Quick links